187 related articles for article (PubMed ID: 20224858)
1. Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms.
Ghazi B; Carlson GW; Murray DR; Gow KW; Page A; Durham M; Kooby DA; Parker D; Rapkin L; Lawson DH; Delman KA
Ann Surg Oncol; 2010 Sep; 17(9):2471-5. PubMed ID: 20224858
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors).
Murali R; Sharma RN; Thompson JF; Stretch JR; Lee CS; McCarthy SW; Scolyer RA
Ann Surg Oncol; 2008 Jan; 15(1):302-9. PubMed ID: 18000712
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features.
Gamblin TC; Edington H; Kirkwood JM; Rao UN
Ann Surg Oncol; 2006 Dec; 13(12):1664-70. PubMed ID: 17024556
[TBL] [Abstract][Full Text] [Related]
4. Atypical spitzoid melanocytic neoplasms with angiotropism: a potential mechanism of locoregional involvement.
Barnhill RL; Kutzner H; Schmidt B; Ali L; Bagot M; Janin A; Lugassy C
Am J Dermatopathol; 2011 May; 33(3):236-43. PubMed ID: 21389834
[TBL] [Abstract][Full Text] [Related]
5. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas.
Busam KJ; Murali R; Pulitzer M; McCarthy SW; Thompson JF; Shaw HM; Brady MS; Coit DG; Dusza S; Wilmott J; Kayton M; Laquaglia M; Scolyer RA
Am J Surg Pathol; 2009 Sep; 33(9):1386-95. PubMed ID: 19609204
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients.
Su LD; Fullen DR; Sondak VK; Johnson TM; Lowe L
Cancer; 2003 Jan; 97(2):499-507. PubMed ID: 12518375
[TBL] [Abstract][Full Text] [Related]
7. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.
Ludgate MW; Fullen DR; Lee J; Lowe L; Bradford C; Geiger J; Schwartz J; Johnson TM
Cancer; 2009 Feb; 115(3):631-41. PubMed ID: 19123453
[TBL] [Abstract][Full Text] [Related]
8. Survival in sentinel lymph node-positive pediatric melanoma.
Roaten JB; Partrick DA; Bensard D; Pearlman N; Gonzalez R; Fitzpatrick J; McCarter MD
J Pediatr Surg; 2005 Jun; 40(6):988-92; discussion 992. PubMed ID: 15991183
[TBL] [Abstract][Full Text] [Related]
9. Age and Breslow depth are associated with a positive sentinel lymph node in patients with cutaneous melanocytic tumors of uncertain malignant potential.
Meyers MO; Yeh JJ; Deal AM; Byerly FL; Woosley JT; Frank J; Long PK; Amos KD; Ollila DW
J Am Coll Surg; 2010 Dec; 211(6):744-8. PubMed ID: 20869269
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
Creager AJ; Shiver SA; Shen P; Geisinger KR; Levine EA
Cancer; 2002 Jun; 94(11):3016-22. PubMed ID: 12115392
[TBL] [Abstract][Full Text] [Related]
11. Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008.
Berk DR; LaBuz E; Dadras SS; Johnson DL; Swetter SM
Pediatr Dermatol; 2010; 27(3):244-54. PubMed ID: 20403119
[TBL] [Abstract][Full Text] [Related]
12. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
13. Melanocytic nevi with Spitz differentiation: diagnosis and management.
Ahmadi N; Davison SP; Kauffman CL
Laryngoscope; 2010 Dec; 120(12):2385-90. PubMed ID: 21072755
[TBL] [Abstract][Full Text] [Related]
14. The role of sentinel node biopsy in the management of melanocytic lesions of uncertain malignant potential (MUMP).
McArthur GJ; Banwell ME; Cook MG; Powell BW
J Plast Reconstr Aesthet Surg; 2007; 60(8):952-4. PubMed ID: 17616368
[TBL] [Abstract][Full Text] [Related]
15. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.
Jakub JW; Huebner M; Shivers S; Nobo C; Puleo C; Harmsen WS; Reintgen DS
Ann Surg Oncol; 2009 Aug; 16(8):2245-51. PubMed ID: 19517194
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
Kunte C; Geimer T; Baumert J; Konz B; Volkenandt M; Flaig M; Ruzicka T; Berking C; Schmid-Wendtner MH
Melanoma Res; 2010 Aug; 20(4):330-7. PubMed ID: 20526218
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
[TBL] [Abstract][Full Text] [Related]
19. Unusual variants of malignant melanoma.
Barnhill RL; Gupta K
Clin Dermatol; 2009; 27(6):564-87. PubMed ID: 19880044
[TBL] [Abstract][Full Text] [Related]
20. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
